News DANZITEN November 14, 2024 Read More » KEBILIDI™ November 13, 2024 Read More » AUCATZYL November 8, 2024 Read More » FDA Approves Emrosi™ for the Treatment of Rosacea November 4, 2024 Read More » GENERIC DRUG APPROVALS November 1, 2024 Read More » ORLYNVAH October 25, 2024 Read More » VYLOY™ October 18, 2024 Read More » VYALEV October 17, 2024 Read More » C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga yOmega 3 Due to the Presence of Undeclared Drug Ingredients October 16, 2024 Read More » Page1 Page2 Page3 Page4 … Page42 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga yOmega 3 Due to the Presence of Undeclared Drug Ingredients October 16, 2024 Read More »